Cargando…
Romosozumab-aqqg in the Treatment of Osteoporosis in a Patient With Hypophosphatasia
Hypophosphatasia is a rare, inherited condition that causes osteomalacia and recurrent fractures. Therapeutic options for osteoporosis in patients with hypophosphatasia are limited because of concerns for a greater likelihood of atypical femoral fractures with antiresorptive agents. We report here t...
Autores principales: | Khanjee, Naveed, Maalouf, Naim M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646966/ https://www.ncbi.nlm.nih.gov/pubmed/36381012 http://dx.doi.org/10.1210/jendso/bvac159 |
Ejemplares similares
-
RF30 | PSAT138 Romosozumab-aqqg in the Treatment of Osteoporosis in a Patient with Hypophosphatasia
por: Khanjee, Naveed, et al.
Publicado: (2022) -
Romosozumab for the treatment of osteoporosis
por: McClung, Michael R.
Publicado: (2018) -
Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis
por: Trepanowski, Nicole, et al.
Publicado: (2023) -
Romosozumab for osteoporosis
Publicado: (2021) -
Osteoporosis Improved by Romosozumab Therapy in a Patient With Type I Osteogenesis Imperfecta
por: Dattagupta, Antara, et al.
Publicado: (2023)